Connection

Youchun Wang to Humans

This is a "connection" page, showing publications Youchun Wang has written about Humans.
Connection Strength

0.153
  1. Lentil lectin derived from Lens culinaris exhibit broad antiviral activities against SARS-CoV-2 variants. Emerg Microbes Infect. 2021 Dec; 10(1):1519-1529.
    View in: PubMed
    Score: 0.008
  2. Cellular tropism and antigenicity of mink-derived SARS-CoV-2 variants. Signal Transduct Target Ther. 2021 05 17; 6(1):196.
    View in: PubMed
    Score: 0.008
  3. SARS-CoV-2 501Y.V2 variants lack higher infectivity but do have immune escape. Cell. 2021 04 29; 184(9):2362-2371.e9.
    View in: PubMed
    Score: 0.007
  4. Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2. Emerg Microbes Infect. 2020 Dec; 9(1):680-686.
    View in: PubMed
    Score: 0.007
  5. Quantification of SARS-CoV-2 neutralizing antibody by a pseudotyped virus-based assay. Nat Protoc. 2020 11; 15(11):3699-3715.
    View in: PubMed
    Score: 0.007
  6. The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity. Cell. 2020 09 03; 182(5):1284-1294.e9.
    View in: PubMed
    Score: 0.007
  7. High seroprevalence of hepatitis E virus in rabbit slaughterhouse workers. Transbound Emerg Dis. 2019 Mar; 66(2):1085-1089.
    View in: PubMed
    Score: 0.006
  8. Antigenic Drift of Influenza A(H7N9) Virus Hemagglutinin. J Infect Dis. 2019 01 01; 219(1):19-25.
    View in: PubMed
    Score: 0.006
  9. Nipah pseudovirus system enables evaluation of vaccines in vitro and in vivo using non-BSL-4 facilities. Emerg Microbes Infect. 2019; 8(1):272-281.
    View in: PubMed
    Score: 0.006
  10. Hepatitis E virus was not detected in feces and milk of cows in Hebei province of China: No evidence for HEV prevalence in cows. Int J Food Microbiol. 2019 Feb 16; 291:5-9.
    View in: PubMed
    Score: 0.006
  11. A Human DPP4-Knockin Mouse's Susceptibility to Infection by Authentic and Pseudotyped MERS-CoV. Viruses. 2018 08 23; 10(9).
    View in: PubMed
    Score: 0.006
  12. Current status on the development of pseudoviruses for enveloped viruses. Rev Med Virol. 2018 01; 28(1).
    View in: PubMed
    Score: 0.006
  13. Development and optimization of a sensitive pseudovirus-based assay for HIV-1 neutralizing antibodies detection using A3R5 cells. Hum Vaccin Immunother. 2018 01 02; 14(1):199-208.
    View in: PubMed
    Score: 0.006
  14. Valuable antibody detection method for classifying hepatitis E virus genotypes. J Med Virol. 2018 01; 90(1):142-147.
    View in: PubMed
    Score: 0.006
  15. RIG-I and IL-6 are negative-feedback regulators of STING induced by double-stranded DNA. PLoS One. 2017; 12(8):e0182961.
    View in: PubMed
    Score: 0.006
  16. Antibody-dependent-cellular-cytotoxicity-inducing antibodies significantly affect the post-exposure treatment of Ebola virus infection. Sci Rep. 2017 03 30; 7:45552.
    View in: PubMed
    Score: 0.006
  17. Neutralizing antibodies against adenovirus type 2 in normal and HIV-1-infected subjects: Implications for use of Ad2 vectors in vaccines. Hum Vaccin Immunother. 2017 06 03; 13(6):1-8.
    View in: PubMed
    Score: 0.006
  18. Performance of the Abbott RealTime HIV-1 assay for quantification of HIV-1 clades prevalent in China. J Clin Virol. 2008 Apr; 41(4):305-9.
    View in: PubMed
    Score: 0.003
  19. Establishment of a reference panel for the detection of anti-SARS-CoV antibodies. Biologicals. 2007 Jun; 35(3):203-10.
    View in: PubMed
    Score: 0.003
  20. [Development and preliminary application of monoclonal antibodies against N protein of SARS virus]. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2004 Sep; 18(3):255-7.
    View in: PubMed
    Score: 0.002
  21. Recombinant chimpanzee adenovirus AdC7 expressing dimeric tandem-repeat spike protein RBD protects mice against COVID-19. Emerg Microbes Infect. 2021 Dec; 10(1):1574-1588.
    View in: PubMed
    Score: 0.002
  22. Structure-based analyses of neutralization antibodies interacting with naturally occurring SARS-CoV-2 RBD variants. Cell Res. 2021 10; 31(10):1126-1129.
    View in: PubMed
    Score: 0.002
  23. Structures of SARS-CoV-2 B.1.351 neutralizing antibodies provide insights into cocktail design against concerning variants. Cell Res. 2021 10; 31(10):1130-1133.
    View in: PubMed
    Score: 0.002
  24. A broadly neutralizing humanized ACE2-targeting antibody against SARS-CoV-2 variants. Nat Commun. 2021 08 17; 12(1):5000.
    View in: PubMed
    Score: 0.002
  25. Discovery and evolution of 12N-substituted aloperine derivatives as anti-SARS-CoV-2 agents through targeting late entry stage. Bioorg Chem. 2021 10; 115:105196.
    View in: PubMed
    Score: 0.002
  26. Potent and protective IGHV3-53/3-66 public antibodies and their shared escape mutant on the spike of SARS-CoV-2. Nat Commun. 2021 07 09; 12(1):4210.
    View in: PubMed
    Score: 0.002
  27. Antibody Cocktail Exhibits Broad Neutralization Activity Against SARS-CoV-2 and SARS-CoV-2 Variants. Virol Sin. 2021 Oct; 36(5):934-947.
    View in: PubMed
    Score: 0.002
  28. The Antigenicity of Epidemic SARS-CoV-2 Variants in the United Kingdom. Front Immunol. 2021; 12:687869.
    View in: PubMed
    Score: 0.002
  29. Humoral immune response to circulating SARS-CoV-2 variants elicited by inactivated and RBD-subunit vaccines. Cell Res. 2021 07; 31(7):732-741.
    View in: PubMed
    Score: 0.002
  30. The first Chinese national standards for SARS-CoV-2 neutralizing antibody. Vaccine. 2021 06 23; 39(28):3724-3730.
    View in: PubMed
    Score: 0.002
  31. Cathepsin L plays a key role in SARS-CoV-2 infection in humans and humanized mice and is a promising target for new drug development. Signal Transduct Target Ther. 2021 03 27; 6(1):134.
    View in: PubMed
    Score: 0.002
  32. Spike-specific circulating T follicular helper cell and cross-neutralizing antibody responses in COVID-19-convalescent individuals. Nat Microbiol. 2021 01; 6(1):51-58.
    View in: PubMed
    Score: 0.002
  33. A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity. Nature. 2020 10; 586(7830):572-577.
    View in: PubMed
    Score: 0.002
  34. Structural basis for neutralization of SARS-CoV-2 and SARS-CoV by a potent therapeutic antibody. Science. 2020 09 18; 369(6510):1505-1509.
    View in: PubMed
    Score: 0.002
  35. A Thermostable mRNA Vaccine against COVID-19. Cell. 2020 09 03; 182(5):1271-1283.e16.
    View in: PubMed
    Score: 0.002
  36. Human neutralizing antibodies elicited by SARS-CoV-2 infection. Nature. 2020 08; 584(7819):115-119.
    View in: PubMed
    Score: 0.002
  37. Discovery and evolution of aloperine derivatives as novel anti-filovirus agents through targeting entry stage. Eur J Med Chem. 2018 Apr 10; 149:45-55.
    View in: PubMed
    Score: 0.002
  38. Proteomic fingerprints for potential application to early diagnosis of severe acute respiratory syndrome. Clin Chem. 2005 Jan; 51(1):56-64.
    View in: PubMed
    Score: 0.001
  39. [Study on the response of specific antibodies against SARS-CoV in patients infected with SARS]. Zhonghua Liu Xing Bing Xue Za Zhi. 2004 Oct; 25(10):856-8.
    View in: PubMed
    Score: 0.001
  40. [Comparison among four kits in detection of anti-SARS-CoV IgG in sera of SARS patients]. Zhonghua Liu Xing Bing Xue Za Zhi. 2004 Jun; 25(6):514-6.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.